Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-06

FDA Approved: ENTECAVIR — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's original ANDA for entecavir, a generic antiviral for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)